SPDR® S&P Pharmaceuticals ETF (XPH)

Delayed Data
As of Nov 16
 +0.16 / +0.37%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that- before fees and expenses- correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index")- the fund employs a sampling strategy. It generally invests substantially all- but at least 80%- of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Midterms Produce Split Congress: ETF Areas in Focus
Nov 08 / Zacks.com - Paid Partner Content
Beaten-Down Pharma ETFs to Buy Post Q3 Results
Nov 06 / Zacks.com - Paid Partner Content


1 month-2.82% 3 years-2.66%
3 months-10.01% 5 years+2.99%
1 year+5.25% Since inception+10.68%
Data through 11/16/2018

Quote Details

Previous close$43.23
Open day’s range42.89 – 43.47
Net asset value (NAV)43.21 (11/15/2018)
Daily volume36,906
Average volume (3 months)104,072
Data as of 3:59pm ET, 11/16/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return+2.99%+14.62%
Expense Gross exp ratio0.35%1.28%
Risk 5 year sharpe ratio0.320.77
Net assets$313.7M$3.2B
Average market cap$9.9B$27.2B
Average P/E11.627.5
Dividend / Share--0.31%


FHLC Fidelity MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Invesco S&P 500® Equal Weight Health Ca...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
ENDP Endo International PLC5.13%
MRK Merck5.06%
LLY Eli Lilly and Co4.93%
ZTS Zoetis Inc4.87%
JNJ Johnson & Johnson4.83%
PFE Pfizer4.82%
JAZZ Jazz Pharmaceuticals PLC4.69%
PRGO Perrigo Company PLC4.59%
AGN Allergan4.04%
MYL Mylan NV4.01%